These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24159599)

  • 41. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
    Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
    Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
    J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Image-guided, minimally invasive surgery and other local therapeutic procedures for primary liver tumors].
    Stippel DL; Wahba R; Bruns CJ; Bunck A; Baues C; Persigehl T
    Chirurg; 2018 Nov; 89(11):872-879. PubMed ID: 30030546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Lin CC; Lui KW; Chen WT; Hsieh YC; Cheng YT; Teng W; Lin SM
    Eur Radiol; 2021 Nov; 31(11):8649-8661. PubMed ID: 33895858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
    Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
    BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma.
    Toshikuni N; Shiroeda H; Ozaki K; Matsue Y; Minato T; Nomura T; Hayashi N; Arisawa T; Tsutsumi M
    Radiol Oncol; 2013; 47(3):224-9. PubMed ID: 24133386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiofrequency ablation of hepatocellular carcinoma: Current status.
    Minami Y; Kudo M
    World J Radiol; 2010 Nov; 2(11):417-24. PubMed ID: 21179308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Advances in Local Thermal Ablation Therapy for Hepatocellular Carcinoma.
    Deng M; Li SH; Guo RP
    Am Surg; 2023 May; 89(5):1966-1973. PubMed ID: 34743609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of navigated radiofrequency ablation for hepatocellular carcinoma in China.
    Lai Y; Li K; Li J; Liu SX
    Int J Technol Assess Health Care; 2014 Oct; 30(4):400-8. PubMed ID: 25682956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.
    Kutlu OC; Chan JA; Aloia TA; Chun YS; Kaseb AO; Passot G; Yamashita S; Vauthey JN; Conrad C
    Cancer; 2017 May; 123(10):1817-1827. PubMed ID: 28085184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2007 Jun; 54(76):985-9. PubMed ID: 17629022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
    Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.